The CardioMetabolic Profile evaluates multiple bloodspot biomarkers relevant to metabolic and cardiovascular health, including fasting insulin, hsCRP, HbA1c, total cholesterol, HDL, LDL, VLDL and triglycerides. These markers help illustrate patterns linked with glucose regulation, lipid balance and systemic inflammation. The profile is designed to support early identification of cardiometabolic tendencies using an at-home bloodspot sample.
Clinically, this assessment may be considered when practitioners are reviewing concerns related to impaired glucose handling, elevated inflammatory markers, abnormal lipid patterns, central adiposity, weight gain, blood pressure concerns or broader cardiovascular tendencies. Because the test captures both glycaemic control (HbA1c, insulin) and lipid dynamics, it can help contextualise risk factors associated with metabolic syndrome.
Practitioners typically interpret these results alongside diet, lifestyle, family history, anthropometrics and other laboratory data. Used in this way, the CardioMetabolic Profile can help guide a more comprehensive understanding of cardiometabolic patterns for clients.